2021年5期
刊物介紹
本刊主要是及時(shí)報(bào)道我國(guó)在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預(yù)防、臨床治療研究方面的新進(jìn)展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學(xué)，實(shí)驗(yàn)?zāi)[瘤學(xué)、腫瘤細(xì)胞分子生物學(xué)，腫瘤病理學(xué)以及腫瘤影像診斷、腫瘤外科治療、化學(xué)治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學(xué)科，旨在促進(jìn)國(guó)內(nèi)外學(xué)術(shù)交流，提高我國(guó)癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
- Esophageal cancer:Epidemiology,risk factors and screening
- Lung cancer risk in never-smokers:An overview of environmental and genetic factors
- Integrating pathomics with radiomics and genomics for cancer prognosis:A brief review
- Coexisting opportunities and challenges:In which scenarios can minimal/measurable residual disease play a role in advancednon-small cell lung cancer?
- Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer:Results from two large Korean cohorts
- A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy
- Better prognostic determination of cT3 rectal cancer through measurement of distance to mesorectal fascia:A multicenter study
- Chidamide combined with cyclophosphamide,doxorubicin,vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma